Entrada Therapeutics Inc (TRDA)

R&D Expense Growth

7.00%

Quarterly · Period ending:

TRDA logo

TRDA R&D Expense Growth

Latest reported7.00%
TRDA Quarterly R&D Growth (QoQ) (0.00% → 7.00%)
High-resolution chart · PNG

TRDA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Entrada Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
7.0037%
-2.6592%
-11.4804%
1.2778%
18.0925%
-3.9873%
6.8753%
-2.4286%
11.9792%
1.1205%
27.4886%
-15.6236%
13.843%
47.2872%
-17.2645%
16.679%
3.3719%
27.1477%
17.5877%
53.9464%
9.7381%
-6.5054%
16.7719%
30.3453%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.